Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo CofiledCriticalSankyo Co
Priority to TW082103794ApriorityCriticalpatent/TW326439B/en
Application grantedgrantedCritical
Publication of TW326439BpublicationCriticalpatent/TW326439B/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
A compound of formula (I): (I) in which: R is hydrogen; X is C1-4 alkyl; A is a single bond, or an C1-6 alkylene; Y is hydrogen, a phenyl which can be substituted by a halogen or C1-4 alkoxy, a heterocyclic group containing 5 or 6 ring atoms in which 1 to 2 hetero atoms are selected from nitrogen, oxygen and sulfur atom; and its pharmacologically acceptable salt and ester.
TW082103794A1993-05-141993-05-14Octahydornaphthalene oxime derivatives for cholesterol biosynthesis inhibition, their preparation and use
TW326439B
(en)
Pharmaceutical compositions comprising hydroxamate derivatives for iron removal from mammalian cells and from pathogenic organisms and some novel hydroxamate derivatives